Navigation Links
Peat and forests save permafrost from melting
Date:9/13/2007

Hamilton, ON. September 13, 2007 Permafrost may be buffered against the impacts of climate change by peat and vegetation present in the northern regions, according to a study by McMaster researchers.

Permafrost is frozen soil that remains at or below 0 oC for at least two consecutive years. Currently, it covers more than 30 per cent of the Earths surface and about 42 per cent (four-million square kilometres) of Canadas land mass.

The study was published recently in Geophysical Research Letters.

There is no doubt that northern regions are warming and permafrost is melting as shown by numerous observations and modeling studies, says Altaf Arain, co-author of the study and associate professor in the School of Geography and Earth Sciences. However, there is large uncertainty about the rate and magnitude of permafrost degradation and thaw depth.

Previous studies using the U.S. National Center for Atmospheric Research Community Climate Model suggest that global warming is rapidly melting permafrost in the North regions. According to those studies, only a million square kilometres of the currently estimated 10.5-million square kilometres of permafrost would remain by the end of this century.

However, Arain says these studies failed to consider the impact of peat and vegetation cover.

A layer of peat above the permafrost acts as insulation by trapping air pockets, which reduce heat transfer and helps permafrost retention, he says. Vegetation can also help slow the rate at which permafrost melts because it shades the ground.

Arain and co-author Dr. Ming-ko (Hok) Woo, professor emeritus at the School of Geography & Earth Sciences, used the NCAR Community Land Model (CLM3) with several modifications and historical climate records. Their results indicated that although permafrost degradation was predicted over the 2000 to 2100 period, areas with mineral-based soil and no vegetation were most affected. <
'/>"/>

Contact: Jane Christmas
chrisja@mcmaster.ca
905-525-9140 x27988
McMaster University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Live fast, die young true for forests too
2. U.N. mulls the protection of Earths forests
3. Expanding forests darken the outlook for butterflies, study shows
4. Emerald Spectre haunts Ontarios ash forests
5. Tropical dry forests receive international recognition
6. Scientists must offer solutions for conserving tropical forests in a rapidly changing world
7. New book on rain forests, slash-and-burn agriculture
8. Diverse tropical forests defy metabolic ecology models
9. Himalayan forests disappearing
10. Report highlights change in Canadas forests
11. Soil nutrition affects carbon sequestration in forests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/21/2015)... Sweden , July 21, 2015 Today, ... FPC1025. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... can lead to cellular changes in the cervix that ... of these pre-stages gives an increased risk of preterm ... pre-stages of cervical cancer, it may therefore reduce the ... calculated the benefits of HPV-vaccination. Cervical cancer ...
... Alexandria, Va. The 2009 Wilmer Souder Award is ... of,Colorado, Aurora, USA. The International Association for Dental Research ... & Exhibition in Miami, Florida, USA, on April 1, ... of Craniofacial Biology at the University of Colorado School ...
... of The Proceedings of the National Academy of Sciences ... "alpha-synuclein dance" the switching back and forth of the ... the surface that it is binding to changes. Such ... like alpha-synuclein, which are known to be unfolded in isolation, ...
Cached Biology News:HPV vaccine may prevent preterm births 2Scripps research scientists 'watch' as individual alpha-synuclein proteins change shape 2Scripps research scientists 'watch' as individual alpha-synuclein proteins change shape 3
(Date:7/31/2015)... ... 31, 2015 , ... R-Biopharm is proud to announce the ... in foods, has been accepted by AOAC International as Official First Action method. ... Cereal-Based Products by R5 Competitive ELISA,” based on a specific monoclonal antibody to ...
(Date:7/30/2015)... Mass. , July 30, 2015   ... solutions for the interpretation and analysis of genomic ... Matthew Fischer has joined the company as ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... capabilities to integrate, interpret, analyze and explore complex ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... March 7, 2012 Karyopharm Therapeutics Inc., a leader ... nine presentations covering its Selective Inhibitors of Nuclear Export ... meeting on March 31 – April 4, 2012, in ... studying the use of Karyopharm,s novel SINE, along with ...
... Inc. (OTC/BB: PROT) announced today that it has ... to which the Company has agreed to sell shares ... aggregate purchase price of approximately $3.8 million (which are ... common stock) and Series A, Series B and Series ...
... NEW YORK, March 5, 2012  Organovo, Inc., (OTCQB: ... on using its breakthrough NovoGen 3D human tissue ... research and medical applications, today announced that their ... on-demand viewing. LINK:    www.retailinvestorconferences.com ...
Cached Biology Technology:Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 2Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 3Proteonomix Announces a Private Placement of $3.8 Million 2Proteonomix Announces a Private Placement of $3.8 Million 3Proteonomix Announces a Private Placement of $3.8 Million 4Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 2
... different Cynomolgus monkey normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
...
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
cysteine and glycine-rich protein 2,...
Biology Products: